National Research (NASDAQ:NRC) Share Price Passes Above Two Hundred Day Moving Average – Should You Sell?

National Research Corporation (NASDAQ:NRC)’s share price crossed above its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of $17.35 and traded as high as $20.21. National Research shares last traded at $19.53, with a volume of 87,434 shares trading hands.

Wall Street Analyst Weigh In

Separately, Weiss Ratings lowered National Research from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Friday, March 6th. One investment analyst has rated the stock with a Sell rating, According to MarketBeat.com, the stock currently has an average rating of “Sell”.

National Research Trading Down 0.7%

The company has a current ratio of 0.52, a quick ratio of 0.52 and a debt-to-equity ratio of 5.48. The firm has a 50-day moving average of $17.87 and a 200 day moving average of $17.35. The company has a market cap of $444.23 million, a P/E ratio of 50.08 and a beta of 0.31.

National Research (NASDAQ:NRC) last announced its quarterly earnings results on Tuesday, April 28th. The company reported $0.21 earnings per share (EPS) for the quarter. The business had revenue of $34.80 million for the quarter. National Research had a return on equity of 122.73% and a net margin of 6.52%.

National Research Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, July 10th. Shareholders of record on Friday, June 26th will be issued a $0.16 dividend. The ex-dividend date is Friday, June 26th. This represents a $0.64 annualized dividend and a yield of 3.3%. National Research’s dividend payout ratio is presently 164.10%.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently added to or reduced their stakes in NRC. Russell Investments Group Ltd. boosted its holdings in National Research by 85.6% in the third quarter. Russell Investments Group Ltd. now owns 1,997 shares of the company’s stock worth $26,000 after acquiring an additional 921 shares in the last quarter. EverSource Wealth Advisors LLC boosted its holdings in National Research by 9,535.3% in the second quarter. EverSource Wealth Advisors LLC now owns 1,638 shares of the company’s stock worth $28,000 after acquiring an additional 1,621 shares in the last quarter. BNP Paribas Financial Markets boosted its holdings in National Research by 85.4% in the third quarter. BNP Paribas Financial Markets now owns 2,496 shares of the company’s stock worth $32,000 after acquiring an additional 1,150 shares in the last quarter. Strs Ohio bought a new position in National Research in the first quarter worth approximately $33,000. Finally, Raymond James Financial Inc. bought a new position in National Research in the second quarter worth approximately $34,000. Institutional investors own 47.26% of the company’s stock.

About National Research

National Research Corp (NASDAQ: NRC), also known as NRC Health, is a healthcare analytics and performance improvement company specializing in patient and employee experience measurement. The company’s cloud-based platform enables healthcare providers to collect real-time feedback through patient satisfaction surveys, post-discharge outreach, and employee engagement tools. NRC Health integrates clinical, operational and financial data to deliver actionable insights that support quality improvement initiatives and value-based care programs.

Since its founding in the early 1990s and headquartered in Lincoln, Nebraska, National Research has expanded beyond its regional roots to serve more than 1,600 hospitals and 12,000 care sites across the United States and Canada.